Day: May 20, 2021

East Stone Acquisition Corporation Announces Sponsor Approval of Extension of Deadline to Complete Business Combination

East Stone Acquisition Corporation Announces Sponsor Approval of Extension of Deadline to Complete Business Combination

Burlington, MA, May 20, 2021 (GLOBE NEWSWIRE) — East Stone Acquisition Corporation (Nasdaq: ESSCU), a publicly traded special purpose acquisition company (“East Stone”), announced today that its sponsor, Double Venture Holdings Limited (the “Sponsor”), has requested that East Stone extend the date by which East Stone has to consummate a business combination from May 24, 2021 to August 24, 2021 (the “Extension”). The Extension is the first of up to two three-month extensions permitted under East Stone’s governing documents. In connection with such Extension, the Sponsor has notified East Stone that it intends to cause an aggregate of $1,380,000 to be deposited into East Stone’s trust account on or before May 24, 2021. The Extension provides East Stone with additional time to complete its proposed business combination with JHD Holdings...

Continue reading

Checkmate Pharmaceuticals to Present at the Jefferies 2021 Virtual Healthcare Conference

Checkmate Pharmaceuticals to Present at the Jefferies 2021 Virtual Healthcare Conference

CAMBRIDGE, Mass., May 20, 2021 (GLOBE NEWSWIRE) — Checkmate Pharmaceuticals Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biopharmaceutical company focused on developing its proprietary technology to harness the power of the immune system to combat cancer, today announced that Barry Labinger, CEO, will present at the Jefferies Virtual Healthcare Conference from 2:00-2:25pm ET on Tuesday, June 1, 2021. Checkmate will also host 1×1 investor meetings during the conference. A live webcast of the presentation can be accessed under “Events & Presentations” in the Investors section of the Checkmate website. An archived copy of the webcast will be available on the Checkmate website for approximately 30 days after the event. About Checkmate Pharmaceuticals Checkmate Pharmaceuticals is a clinical stage biotechnology company...

Continue reading

<div>II-VI Incorporated to Present at the Cowen 49th Annual Technology, Media & Telecom Conference</div>

II-VI Incorporated to Present at the Cowen 49th Annual Technology, Media & Telecom Conference

PITTSBURGH, May 20, 2021 (GLOBE NEWSWIRE) — II-VI Incorporated (Nasdaq: IIVI), a global leader in engineered materials and optoelectronic components, today announced that the Company will present at the following upcoming investor conference: Cowen 49th Annual Technology, Media & Telecom Conference Date:         Tuesday, June 1, 2021 Time:         11:10 a.m. ET Place:         Virtual Participants Dr. Chuck Mattera, Chief Executive Officer, II-VI Mary Jane Raymond, Chief Financial Officer, II-VI A real-time audio webcast of the presentation can be accessed via the Investors section of the II-VI website at https://www.ii-vi.com/investors-events/. A replay of the webcast will be available on the Company’s website following the conclusion of the event. About II-VI Incorporated II-VI Incorporated, a global leader in engineered...

Continue reading

Arvinas to Present at the UBS Global Healthcare Virtual Conference

Arvinas to Present at the UBS Global Healthcare Virtual Conference

NEW HAVEN, Conn., May 20, 2021 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that John Houston, Ph.D., President and Chief Executive Officer and Ian Taylor, Ph.D., Chief Scientific Officer, will participate in a fireside chat at the UBS Global Healthcare Virtual Conference on Tuesday, May 25 at 10:00 a.m. ET. A live audio webcast of the presentation will be available here and on Arvinas’ website at www.arvinas.com. A replay of the webcast will be archived on Arvinas’ website for 30 days following the presentation. About ArvinasArvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery,...

Continue reading

Fireweed Closes $5.0 Million Private Placement with Strategic Investor

Fireweed Closes $5.0 Million Private Placement with Strategic Investor

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 20, 2021 (GLOBE NEWSWIRE) — FIREWEED ZINC LTD. (“Fireweed” or the “Company”) (TSXV: FWZ) is pleased to announce closing of its non-brokered private placement (the “Financing”) announced April 22, 2021 for proceeds of CAD$5.0 million consisting of 6,250,000 common shares of the Company (“Shares”) at $0.80 per Share with a single strategic investor. The proceeds from the Financing will be used for general working capital purposes, cash reserves for future development, and exploration and development of the Company’s Macmillan Pass Project in Yukon, Canada. Closing of the Financing remains subject to acceptance by the TSX Venture Exchange. All Shares issued under the Financing will be subject to a statutory...

Continue reading

SmileDirectClub to Participate in Investor Conferences

SmileDirectClub to Participate in Investor Conferences

NASHVILLE, Tenn., May 20, 2021 (GLOBE NEWSWIRE) — SmileDirectClub, Inc. (Nasdaq: SDC), the next generation oral care company with the first medtech platform for teeth straightening, today announced that management will attend several upcoming investor conferences beginning on Monday, May 24th. UBS Global Healthcare Virtual Conference Date: May 24-26, 2021 Presentation Time: Tuesday, May 25 at 2 p.m. ET J.P. Morgan 49th Annual Global Technology, Media and Communications Conference Date: May 24-26, 2021 Presentation Time: Wednesday, May 26 at 4:25 p.m. ET William Blair 41st Annual Growth Stock Conference Date: June 1-3, 2021 Presentation Time: Tuesday, June 1 at 12:20 p.m. ET  Craig Hallum Institutional Investor Conference Date: Wednesday, June 2, 2021 Stifel 2021 Jaws and Paws Conference Date: June 2-3, 2021 Presentation...

Continue reading

TrustCo announces annual meeting results and implementation of reverse stock split

TrustCo announces annual meeting results and implementation of reverse stock split

GLENVILLE, N.Y., May 20, 2021 (GLOBE NEWSWIRE) — The Board of Directors of TrustCo Bank Corp NY (TrustCo, Nasdaq: TRST) today announced the results of its 2021 Annual Meeting of Shareholders. The Company announced that the following individuals were elected as directors to serve terms expiring at the 2022 annual meeting: Lisa M. Lucarelli, Thomas O. Maggs, Anthony J. Marinello MD, PhD, Robert J. McCormick, Kimberly A. Russell, and Frank B. Silverman, with each director securing more than 90% of votes cast. Shareholders also expressed strong support for the advisory resolution on the compensation of the company’s executive officers. Likewise, the shareholders approved a reverse stock split of TrustCo’s Common Stock at a ratio of 1 for 5 and an amendment to TrustCo’s Amended and Restated Certificate of Incorporation to effect a reverse...

Continue reading

MICT, Inc. to Announce First Quarter Financial Results on Monday, May 24, 2021; Company to Hold Conference Call and Provide Corporate Update at 8:30 AM ET [Request for Submitted Questions for the Call]

MICT, Inc. to Announce First Quarter Financial Results on Monday, May 24, 2021; Company to Hold Conference Call and Provide Corporate Update at 8:30 AM ET [Request for Submitted Questions for the Call]

MONTVALE, N.J., May 20, 2021 (GLOBE NEWSWIRE) — MICT, Inc. (Nasdaq: MICT), (the “Company”), today announced today announces it will report first quarter 2021 financial results on Monday, May 24, 2021 before the market opens. Management will host a conference call on Monday, May 24 at 8:30 a.m. ET to review financial results and provide an update on corporate developments. Following management’s formal remarks, there will be a question-and-answer session. Participants are asked to pre-register for the call through the following link: https://dpregister.com/sreg/10156679/e8aa09b9c5. Please note that registered participants will receive their dial in number upon registration and will dial directly into the call without delay. Those without internet access or unable to pre-register may dial in by calling: 1-866-777-2509...

Continue reading

Forsys Announces Annual Meeting Voting Results

Forsys Announces Annual Meeting Voting Results

TORONTO, May 20, 2021 (GLOBE NEWSWIRE) — Forsys Metals Corp. (TSX: FSY) (FSE: F2T) (NSX: FSY) (“Forsys” or the “Company”) is pleased to announce that in connection with the annual meeting of the Company`s shareholders (the “Meeting”), that due to the ongoing COVID-19 pandemic was held virtually on May 20, 2021, and in accordance with TSX reporting requirements, the following voting results were obtained. A total of 99,517,667 common shares representing 59.63% of the Company`s issued and outstanding common shares were voted in connection with the Meeting. Shareholders voted in favour of the election of the six director nominees as follows: NOMINEE VOTES FOR % FOR VOTES WITHHELD % WITHHELD Martin Rowley 99,142,413 99.996 3,920 0.004 Mark Frewin 96,125,163 96.953 3,021,170 3.047 Paul Matysek 96,125,163 96.953 3,021,170 3.047 Jorge...

Continue reading

Affimed Announces Virtual Annual General Meeting of Shareholders

Affimed Announces Virtual Annual General Meeting of Shareholders

Heidelberg, Germany, May 20, 2021 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that its 2021 Annual General Meeting of Shareholders (the “Annual Meeting”) will be held on June 15, 2021 at 17:30 PM CET (11:30 AM EDT). Due to the continuing COVID-19 pandemic and out of concern for the health and safety of shareholders and other attendees, the Annual Meeting will be held virtually and can be followed by visiting www.virtualshareholdermeeting.com/AFMD2021, in accordance with the instructions provided in the notice of the meeting.  Shareholders will not be able to attend the Annual Meeting in person. The notice and agenda of the Annual Meeting are available on Affimed’s website at https://www.affimed.com/investors/ under “Annual...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.